Article and Video CATEGORIES
Ramy Sedhom, MD, is a Medical Oncology Fellow at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland.
He is interested in Supportive and Palliative Care for patients across the cancer continuum - from a clinical, research, and policy perspective. Following his oncology training, he will be pursuing a clinical fellowship in Hospice and Palliative Care.
GRACE is excited to bring you new information in our Bladder Cancer Program, hosted by Ramy Sedhom, MD.
For this first video of 2019, Dr. Ramy Sedhom introduces us to Dr. Elizabeth Plimack with Fox Chase Cancer Center. Dr. Plimack is with the department of Hematology and Oncology at Fox Chase Cancer Center, specializing in bladder, kidney, penile, prostate, testicular and ureteral and urethral cancers. You can read more about Dr. Plimack here. In this video, Drs. Sedhom and Plimack discuss the role of immunotherapy in bladder cancer.
If you have questions or comments, please feel free to join the conversation at https://cancergrace.org/forums/bladder-cancer.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...
Recent Comments
That's…